Methocarbamol
- Product NDC
- 68071-1874
- 11-digit product format
- 680711874
- Labeler code
- 68071
- Product ID
- 68071-1874_3e49f7ce-c741-364b-e054-00144ff88e88
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Methocarbamol
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals, Inc.
- Application
- ANDA200958
- Marketing category
- ANDA
- Marketing start
- 2015-07-13
- Marketing end
- 0000-00-00
- Substance
- METHOCARBAMOL
- Active strength
- 500 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-1874-2 | 2020-06-26 | C162847 | 48780-1 | 9d75b9d1-11f4-f424-e053-dadaa90a57ce | 3e49f7ce-c740-364b-e054-00144ff88e88 |
| 68071-1874-3 | 2020-06-26 | C162847 | 48780-1 | 9d75b9d1-11f4-f424-e053-dadaa90a57ce | 3e49f7ce-c740-364b-e054-00144ff88e88 |
| 68071-1874-6 | 2020-06-26 | C162847 | 48780-1 | 9d75b9d1-11f4-f424-e053-dadaa90a57ce | 3e49f7ce-c740-364b-e054-00144ff88e88 |
| 68071-1874-8 | 2020-06-26 | C162847 | 48780-1 | 9d75b9d1-11f4-f424-e053-dadaa90a57ce | 3e49f7ce-c740-364b-e054-00144ff88e88 |
| 68071-1874-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-11f4-f424-e053-dadaa90a57ce | 3e49f7ce-c740-364b-e054-00144ff88e88 |
| 68071-1874-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-11f4-f424-e053-dadaa90a57ce | 3e49f7ce-c740-364b-e054-00144ff88e88 |
| 68071-1874-6 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-11f4-f424-e053-dadaa90a57ce | 3e49f7ce-c740-364b-e054-00144ff88e88 |
| 68071-1874-8 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-11f4-f424-e053-dadaa90a57ce | 3e49f7ce-c740-364b-e054-00144ff88e88 |